Christian Borgniet

Vivaldi Biosciences Inc. develops and markets vaccines. It specializes in developing live attenuated influenza vaccines (LAIVs). The company was founded by Eliott Kieff, Peter Palese, and Adolfo García-Sastre in 2006 and is headquartered in Fort Collins, CO.

Société Régionale d'Investissement de Wallonie SA (SRIW) is a private equity & venture capital firm , a subsidiary of Region of Wallonia founded in 1979. Société Régionale d'Investissement de Wallonie SA is headquartered in Liege, Belgium.

KitoZyme SA manufactures biopolymers and provides medical device products. It develops and produces chitosan (and derivatives), chitin-glucan and beta-glucan, exclusively extracted from renewable, non-GMO vegetable sources. The firm specializes in weight management, digestive health and cardiovascular health products. The company was founded in December 2000 and is headquartered in Herstal, Belgium.

DNAVision SA operates as a research and development company. The firm provides genomic services to the pharmaceutical, food and biotechnology industries. It offers Non-Executive Directortgen seqencing, bioinformatics, sanger sequence, expression profiling, DNA extraction and biobanking. The company was founded in May 2004 and is headquartered in Charleroi, Belgium.

FIDE Capital SA is an independent wealth management firm headquartered in Brussels, Belgium. The firm was founded in 1996 as Compagnie de Gestion Privée and became FIDE Capital SA in 2012. It offers discretionary asset management services or investment advice.

Artelis is a technology company that provides disposable bio process solutions, from optimization to intensification: ' Process intensification: design, development and manufacturing of innovative high-cell-density technologies that enable to dramatically increase volumetric productivity while significantly reduce the manufacturing scales. ' Process optimization: process development services with a view to improve customer's process Artelis' team comprises 40 individuals all of whom are highly experienced in cell culture and well aware of biotechnology companies' needs.

Ovizio Imaging Systems SA develops and markets imaging systems and sensors. Its microscopes include iLine F, iLine M, iLine S and QMod. The company was founded by Catherine Yourassowsky, Frank Dubois, Philip Mathuis and Serge Jooris in December 2009 and is headquartered in Brussels, Belgium.

ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium.

MaSTherCell SA engages in providing cell therapy manufacturing services. The company was founded in 2011 and is headquartered in Charleroi, Belgium.

Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium.

Univercells SA designs single-use cost-efficient bioprocess solutions to open the next chapter in bio manufacturing. The company was founded by Jose Castillo, Guillaume De Viron and Hugues Bultot in 2013 and is headquartered in Gosselies, Belgium.

ImmunXperts SA provides risk assesment services to the pharmaceutical industy. It offers services to support client in the risk assessment and mitigation of drug candidate’s immunogenicity profile. The firm provides package to its customers, allowing to outsource the full immunogenicity assessment, or to cherry-pick the solutions or technologies needed/that fit client's exact requirements. The company was founded by Sofie Pattijn, Philippe Stas and Arno Kromminga in 2014 and is headquartered in Charleroi, Belgium.

3d-Side SA engages in the development and production of surgical tools and software that provide surgeons with cranial implants and solutions for bone surgery. It offers bone tumor resection, skullPT, 3D (three dimension) model, and corrective osteotomy. The company was founded by Laurent Paul and Khanh Tran Duy and is headquartered in Mont-Saint-Guibert, Belgium.

BCI Pharma SAS engages in research and development in biotechnology. Its kinase platform is based on a new chemotype with phys-chem properties, able to explore a new chemical space for treating CNS, inflammation, cancer and metabolic diseases. The firm also offers medicinal chemistry, HTS platform and consultancy services. The company was founded by Elisabeth Picou and Dominique Surleraux in March 2013 and is headquartered in Grabels, France.

TheClubDeal Capital Advisors SA (Private Equity) is a private equity/venture capital division of TheClubDeal Capital Advisors SA founded in 2016 by Nicolas de Moreau and Jean-Marc Legrand. The firm headquartered in Brussels, Belgium.

TheClubDeal Capital Advisors SA is a venture capital and private equity fund manager that invests in scale-ups and SMEs in the technology sector, both digital and industrial. The private company is based in Brussels, Belgium, and has subsidiaries in northern Belgium. TheClubDeal seeks to create alliances beyond financial investment and looks for entrepreneurs who are entirely committed to their ventures. TheClubDeal has been advising and investing in promising ventures since 2016 and has a structured deals fund of €0M and a target of €0M for its second fund, as well as a co-investment capacity target. The Belgian company was founded by Jean-Marc Legrand, who has been the CEO since its incorporation.

Catalent MSTC, Inc. provides full service contract development and manufacturing services (CDMO) for cell therapy companies. It offers process and assay development, quality management, and cGMP cell therapy manufacturing services. The company was incorporated on December 27, 2017 and is headquartered in Dover, DE.

YUST Group NV provides real estate services. The company is based in Antwerp, Belgium and has subsidiaries in Belgium. The Belgian company was founded in 2018. Stephane Verbeeck has been the CEO of the company since 2019.

Ncardia Holding SA provides biotech research and development, business management consulting, technical testing, and administrative services. The private company is based in Mont-Saint-Guibert, Belgium. The Belgian company was founded in 2014. Stefan Braam has been the CEO of the company since 2015.

Opera Ballet Vlaanderen VZW is a performing arts company based in Antwerp, Belgium. The Belgian company engages in performing arts and related activities. The CEO of the non-profit company is Jan Raes.

THERAtRAME SA is a drug discovery start-up company based in Liege, Belgium. The Belgian company aims to become a leader in the development and positioning of novel cancer therapies by exploring new target areas to develop innovative cancer therapies. THERAtRAME's discovery platform integrates unique sets of technologies to discover, develop, and position new drugs to beat reluctant cancers. The company exploits the latest scientific discoveries highlighting the unexpected importance of trna epitranscriptomics dynamics in cancer. THERAtRAME is looking for a drug discovery assay developer leader to join their team. The company was founded by Francesca Rapino, Pierre Close, and has a team of experienced professionals with backgrounds in life sciences, medico-marketing, and biotech venture creations.